Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test

scientific article published on 19 March 2020

Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000505854
P932PMC publication ID7272266
P698PubMed publication ID32191943

P50authorKenneth OffitQ20732365
P2093author name stringJennifer L Hay
Elyse Shuk
Mark E Robson
Jada G Hamilton
Margaux Genoff Garzon
Kechna Cadet
Joy S Westerman
Ibrahim H Shah
P2860cites workAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesQ24531993
Identifying patient preferences for communicating risk estimates: a descriptive pilot studyQ24804138
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskQ27008356
Visualizing uncertainty about the futureQ28247559
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumQ29619206
Public preferences for communicating personal genomic risk information: a focus group studyQ30830961
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomyQ33425460
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersQ33614244
Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomyQ33650424
Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled TrialQ33654267
Common genetic variants and modification of penetrance of BRCA2-associated breast cancerQ33742096
Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testingQ34206524
Design features of graphs in health risk communication: a systematic reviewQ34560021
Measuring numeracy without a math test: development of the Subjective Numeracy ScaleQ34653859
Communication of uncertainty regarding individualized cancer risk estimates: effects and influential factorsQ34910890
Distress among women receiving uninformative BRCA1/2 results: 12-month outcomesQ34944244
Using icon arrays to communicate medical risks: overcoming low numeracyQ34963595
Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.Q35016127
Varieties of uncertainty in health care: a conceptual taxonomyQ35136761
Helping patients decide: ten steps to better risk communicationQ35557031
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfactionQ36634289
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskQ36720814
Clinical practice. Management of an inherited predisposition to breast cancerQ36877519
Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.Q36936080
Improving communication of breast cancer recurrence riskQ37124483
Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutationQ37187673
Communicating genetic risk information for common disorders in the era of genomic medicineQ37389775
Understanding the role of numeracy in health: proposed theoretical framework and practical insightsQ37441414
Blocks, ovals, or people? Icon type affects risk perceptions and recall of pictographsQ37710250
What are effective strategies to communicate cardiovascular risk information to patients? A systematic reviewQ37753072
Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriersQ37834134
Evidence-based risk communication: a systematic review.Q38240901
Information Mismatch: Cancer Risk Counseling with Diverse Underserved PatientsQ38910083
Angelina Jolie's faulty gene: newspaper coverage of a celebrity's preventive bilateral mastectomy in Canada, the United States, and the United KingdomQ39290572
Intolerance of uncertainty and perceived threatQ40156857
Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test resultsQ40281377
The impact of the format of graphical presentation on health-related knowledge and treatment choicesQ42595775
Perceptions of high-risk care and barriers to care among women at risk for hereditary breast and ovarian cancer following genetic counseling in the community settingQ43565913
The Angelina effect: immediate reach, grasp, and impact of going publicQ44549915
Stress and genetic testing for disease riskQ45293779
Uncertainty in BRCA1 cancer susceptibility testingQ46215001
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupQ47189470
Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian CancerQ47362978
Do icon arrays help reduce denominator neglect?Q51696450
Validation of the Subjective Numeracy Scale: effects of low numeracy on comprehension of risk communications and utility elicitations.Q51901185
Reducing the influence of anecdotal reasoning on people's health care decisions: is a picture worth a thousand statistics?Q51967791
Pictorial superiority effect.Q52111843
Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessmentQ57947279
High-risk women's risk perception after receiving personalized polygenic breast cancer risk information.Q64934338
Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluationQ80080574
The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communicationQ82258287
Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic riskQ91712928
Understanding BRCA Mutation Carriers' Preferences for Communication of Genetic Modifiers of Breast Cancer RiskQ91797697
Uptake of polygenic risk information among women at increased risk of breast cancerQ91944719
What Are Polygenic Scores and Why Are They Important?Q92926448
P921main subjectrisk communicationQ24889807
P304page(s)1-14
P577publication date2020-03-19
P1433published inPublic Health GenomicsQ15766289
P1476titleIllustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test

Search more.